vs

Side-by-side financial comparison of Reservoir Media, Inc. (RSVR) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.

SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $45.6M, roughly 1.4× Reservoir Media, Inc.). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 4.8%, a 34.6% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $12.8M).

Reservoir Media, Inc. is a leading global independent music rights management company. It owns and administers extensive catalogs of recorded music, music publishing copyrights, and neighboring rights, partnering with top songwriters, performing artists, and producers across genres including pop, hip-hop, rock, and film soundtracks. It licenses its content for use across streaming platforms, advertising, film and television productions, live events, and other commercial channels, with operations spanning North America, Europe, and Asia Pacific markets.

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

RSVR vs SLNO — Head-to-Head

Bigger by revenue
SLNO
SLNO
1.4× larger
SLNO
$66.0M
$45.6M
RSVR
Higher net margin
SLNO
SLNO
34.6% more per $
SLNO
39.4%
4.8%
RSVR
More free cash flow
SLNO
SLNO
$30.7M more FCF
SLNO
$43.5M
$12.8M
RSVR

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
RSVR
RSVR
SLNO
SLNO
Revenue
$45.6M
$66.0M
Net Profit
$2.2M
$26.0M
Gross Margin
64.5%
98.3%
Operating Margin
22.7%
33.5%
Net Margin
4.8%
39.4%
Revenue YoY
7.7%
Net Profit YoY
-58.1%
134.0%
EPS (diluted)
$0.03
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RSVR
RSVR
SLNO
SLNO
Q4 25
$45.6M
Q3 25
$45.4M
$66.0M
Q2 25
$37.2M
$32.7M
Q1 25
$41.4M
Q4 24
$42.3M
Q3 24
$40.7M
Q2 24
$34.3M
Q1 24
$39.1M
Net Profit
RSVR
RSVR
SLNO
SLNO
Q4 25
$2.2M
Q3 25
$2.3M
$26.0M
Q2 25
$-555.7K
$-4.7M
Q1 25
$2.7M
Q4 24
$5.2M
Q3 24
$185.0K
Q2 24
$-346.7K
Q1 24
$2.8M
Gross Margin
RSVR
RSVR
SLNO
SLNO
Q4 25
64.5%
Q3 25
63.6%
98.3%
Q2 25
64.5%
97.9%
Q1 25
65.6%
Q4 24
64.4%
Q3 24
63.5%
Q2 24
61.3%
Q1 24
63.4%
Operating Margin
RSVR
RSVR
SLNO
SLNO
Q4 25
22.7%
Q3 25
23.5%
33.5%
Q2 25
14.7%
-20.0%
Q1 25
25.2%
Q4 24
22.6%
Q3 24
24.9%
Q2 24
14.5%
Q1 24
22.4%
Net Margin
RSVR
RSVR
SLNO
SLNO
Q4 25
4.8%
Q3 25
5.0%
39.4%
Q2 25
-1.5%
-14.4%
Q1 25
6.4%
Q4 24
12.4%
Q3 24
0.5%
Q2 24
-1.0%
Q1 24
7.1%
EPS (diluted)
RSVR
RSVR
SLNO
SLNO
Q4 25
$0.03
Q3 25
$0.03
$0.47
Q2 25
$-0.01
$-0.09
Q1 25
Q4 24
$0.08
Q3 24
Q2 24
$-0.01
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RSVR
RSVR
SLNO
SLNO
Cash + ST InvestmentsLiquidity on hand
$20.6M
$498.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$373.6M
$494.8M
Total Assets
$941.9M
$599.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RSVR
RSVR
SLNO
SLNO
Q4 25
$20.6M
Q3 25
$27.9M
$498.9M
Q2 25
$14.9M
$286.8M
Q1 25
$21.4M
Q4 24
$17.8M
Q3 24
$21.1M
Q2 24
$16.4M
Q1 24
$18.1M
Stockholders' Equity
RSVR
RSVR
SLNO
SLNO
Q4 25
$373.6M
Q3 25
$370.9M
$494.8M
Q2 25
$368.9M
$240.1M
Q1 25
$364.9M
Q4 24
$359.5M
Q3 24
$357.9M
Q2 24
$353.0M
Q1 24
$353.0M
Total Assets
RSVR
RSVR
SLNO
SLNO
Q4 25
$941.9M
Q3 25
$903.5M
$599.9M
Q2 25
$857.0M
$332.3M
Q1 25
$865.1M
Q4 24
$832.4M
Q3 24
$778.2M
Q2 24
$768.2M
Q1 24
$783.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RSVR
RSVR
SLNO
SLNO
Operating Cash FlowLast quarter
$12.9M
$43.5M
Free Cash FlowOCF − Capex
$12.8M
$43.5M
FCF MarginFCF / Revenue
28.1%
65.8%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
5.89×
1.67×
TTM Free Cash FlowTrailing 4 quarters
$50.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RSVR
RSVR
SLNO
SLNO
Q4 25
$12.9M
Q3 25
$19.3M
$43.5M
Q2 25
$6.0M
$-12.6M
Q1 25
$12.2M
Q4 24
$11.2M
Q3 24
$13.3M
Q2 24
$8.6M
Q1 24
$13.8M
Free Cash Flow
RSVR
RSVR
SLNO
SLNO
Q4 25
$12.8M
Q3 25
$19.2M
$43.5M
Q2 25
$6.0M
$-12.6M
Q1 25
$12.2M
Q4 24
$11.2M
Q3 24
$13.3M
Q2 24
$8.5M
Q1 24
$13.8M
FCF Margin
RSVR
RSVR
SLNO
SLNO
Q4 25
28.1%
Q3 25
42.2%
65.8%
Q2 25
16.1%
-38.6%
Q1 25
29.3%
Q4 24
26.5%
Q3 24
32.7%
Q2 24
24.9%
Q1 24
35.2%
Capex Intensity
RSVR
RSVR
SLNO
SLNO
Q4 25
0.3%
Q3 25
0.3%
0.0%
Q2 25
0.1%
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
RSVR
RSVR
SLNO
SLNO
Q4 25
5.89×
Q3 25
8.54×
1.67×
Q2 25
Q1 25
4.56×
Q4 24
2.14×
Q3 24
71.97×
Q2 24
Q1 24
4.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RSVR
RSVR

Other$18.9M42%
Recorded Music Segment$12.9M28%
Performance$6.2M14%
Synchronization$4.6M10%
Physical$1.9M4%
Neighboring Rights$1.1M3%

SLNO
SLNO

Segment breakdown not available.

Related Comparisons